AMENDED AND RESTATED STOCKHOLDERS AGREEMENTStockholders Agreement • August 6th, 2019 • Silk Road Medical Inc • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledAugust 6th, 2019 Company Industry JurisdictionThis Amended and Restated Stockholders Agreement (this “Agreement”) is dated as of this 7th day of July, 2017 and entered into by and among the institutional investors listed on Schedule I hereto (the “Institutional Investors”); the individuals whose names and addresses appear from time to time on Schedule II hereto (the “Other Investors”); and Silk Road Medical, Inc., a Delaware corporation (the “Company”). The Institutional Investors and the Other Investors are hereinafter each referred to as an “Investor” and collectively referred to as the “Investors”.
AMENDED AND RESTATED STOCKHOLDERS AGREEMENTStockholders Agreement • March 4th, 2019 • Silk Road Medical Inc • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledMarch 4th, 2019 Company Industry JurisdictionThis Amended and Restated Stockholders Agreement (this “Agreement”) is dated as of this 7th day of July, 2017 and entered into by and among the institutional investors listed on Schedule I hereto (the “Institutional Investors”); the individuals whose names and addresses appear from time to time on Schedule II hereto (the “Other Investors”); and Silk Road Medical, Inc., a Delaware corporation (the “Company”). The Institutional Investors and the Other Investors are hereinafter each referred to as an “Investor” and collectively referred to as the “Investors”.
AMENDED AND RESTATED STOCKHOLDERS AGREEMENTStockholders Agreement • December 19th, 2018 • Silk Road Medical Inc • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledDecember 19th, 2018 Company Industry JurisdictionThis Amended and Restated Stockholders Agreement (this “Agreement”) is dated as of this 7th day of July, 2017 and entered into by and among the institutional investors listed on Schedule I hereto (the “Institutional Investors”); the individuals whose names and addresses appear from time to time on Schedule II hereto (the “Other Investors”); and Silk Road Medical, Inc., a Delaware corporation (the “Company”). The Institutional Investors and the Other Investors are hereinafter each referred to as an “Investor” and collectively referred to as the “Investors”.